{"id":583343,"date":"2022-01-24T17:22:01","date_gmt":"2022-01-24T17:22:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=583343"},"modified":"2022-01-24T17:22:01","modified_gmt":"2022-01-24T17:22:01","slug":"cancer-cachexia-market-industry-trends-companies-drugs-and-analysis-by-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/cancer-cachexia-market-industry-trends-companies-drugs-and-analysis-by-delveinsight_583343.html","title":{"rendered":"Cancer Cachexia Market, Industry Trends, Companies, Drugs and Analysis by DelveInsight"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1643023062.png\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Cancer Cachexia Market, Industry Trends, Companies, Drugs and Analysis by DelveInsight\" src=\"https:\/\/www.abnewswire.com\/uploads\/1643023062.png\" alt=\"Cancer Cachexia Market, Industry Trends, Companies, Drugs and Analysis by DelveInsight\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>Cancer Cachexia Market<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">The total Cancer Cachexia market size will include the market size of both potential upcoming Cancer Cachexia therapies and current Cancer Cachexia treatment regimens.<\/div>\n<p style=\"text-align: justify;\" dir=\"ltr\"><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/uploads\/b4f745b926f948e984163d2e20faf080.jpg\" alt=\"\" \/><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">DelveInsight&rsquo;s <strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/cancer-cachexia-cc-market-insights?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Cancer Cachexia market report<\/a><\/strong> thoroughly explains Cancer Cachexia, historical and forecasted epidemiology, and the Cancer Cachexia market trends in the 7MM.&nbsp;<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Key Highlights from the Cancer Cachexia Market Report<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">Several secondary studies indicate that the overall incidence of cachexia is high and that it is increasing in industrialized countries such as North America, Europe, and Japan.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">According to a Japanese study titled &#8220;Cancer cachexia, mechanism and treatment&#8221; conducted by Aoyagi et al., cachexia occurs in most terminal cancer patients and is responsible for the death of<strong> 22%<\/strong> of cancer patients.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Leading companies in the Cancer Cachexia market include <strong>Pfizer, Actimed Therapeutics, Incyte Corporation, Aveo Oncology, Extend Biosciences,<\/strong> and others.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Key Cancer Cachexia therapies in the pipeline <strong>PF 06946860, ACM-001, Jakafi, AV-380, EXT418,<\/strong> and others.<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\"><strong>Actimed Therapeutics<\/strong> is currently developing <strong>ACM-001 (S-pindolol)<\/strong>, formerly known as <strong>MT-102<\/strong>, which has completed a phase II trial (ACT-ONE) in patients with cachexia caused by stage III or IV non-small cell lung cancer (NSCLC) or colorectal cancer (CRC).<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\">Have queries? Request for the sample @ <strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/cancer-cachexia-cc-market-insights?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Cancer Cachexia Market Outlook<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Cancer Cachexia Overview<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">Cancer Cachexia is a wasting syndrome marked by weight loss, anorexia (loss of appetite), asthenia, and anemia. This syndrome&#8217;s pathogenicity is multifactorial due to a complex tumor and host factors interaction. Patients with advanced cancer, chronic obstructive pulmonary disease, chronic infection including AIDS and tuberculosis, chronic heart failure, and rheumatoid arthritis are at risk.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Cancer Cachexia Epidemiology Segmentation<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">The Cancer Cachexia report proffers epidemiological analysis for the study period 2019-32 in the 7MM segmented into:&nbsp;<\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">Cancer Cachexia Incident\/Prevalent Cases&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Cancer Cachexia Diagnosed Cases&nbsp;<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Cancer Cachexia Treatable Cases&nbsp;<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Cancer Cachexia Treatment Landscape&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">Currently, the potential treatment options available for cancer cachexia include Nutritional counseling or Appetite stimulants (Progestational agents, Ghrelin, Cannabinoids, and Corticosteroids), Cytokine-based therapeutic approaches, and Anabolic Steroids (non-steroidal selective androgen receptor modulator (SARM).<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Cancer Cachexia Market Outlook<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">In the seven major markets, the total Cancer Cachexia market size will include the market size of both potential upcoming Cancer Cachexia therapies and current Cancer Cachexia treatment regimens.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">Discover more about the future market share of the drugs @ <strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/cancer-cachexia-cc-market-insights?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Cancer Cachexia Market Analysis<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Cancer Cachexia Pipeline Therapies and Key Companies<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li dir=\"ltr\">\n<p dir=\"ltr\">PF 06946860: Pfizer<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">ACM-001: Actimed Therapeutics<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">Jakafi: Incyte Corporation<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">AV-380: Aveo Oncology<\/p>\n<\/li>\n<li dir=\"ltr\">\n<p dir=\"ltr\">EXT418: Extend Biosciences<\/p>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Table of Contents<\/strong><\/p>\n<div style=\"text-align: justify;\" dir=\"ltr\" align=\"left\">\n<table>\n<colgroup>\n<col width=\"71\" \/>\n<col width=\"553\" \/><\/colgroup>\n<tbody>\n<tr>\n<td>\n<p dir=\"ltr\">1.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Report Introduction<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">2.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Cancer Cachexia: Market Overview at a Glance<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">3.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Disease Background and Overview: Cancer Cachexia<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">4.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Epidemiology and Patient Population<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">5.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Cancer Cachexia: Country-Wise Epidemiology<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">6.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">United States<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">7.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Treatments &amp; Medical Practices<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">8.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Current Treatment<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">9.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Emerging Therapies<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">10.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Key Cross Competition<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">11.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Cancer Cachexia Market Size<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">12.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">7MM Cancer Cachexia: Country-Wise Market Analysis<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">13.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">United States Market Size<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">14.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">EU5 Market Size<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">15.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Japan Market Size<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">16.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Report Methodology<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">17.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">DelveInsight Capabilities<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">18.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">Disclaimer<\/p>\n<\/td>\n<\/tr>\n<tr>\n<td>\n<p dir=\"ltr\">19.<\/p>\n<\/td>\n<td>\n<p dir=\"ltr\">About DelveInsight<\/p>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p style=\"text-align: justify;\" dir=\"ltr\">Get in touch with our business executive for <strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/consulting\/due-diligence-services?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Healthcare Due Diligence Services<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>Related Reports<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/cancer-anorexia-cachexia-syndrome-market?utm_source=Abnewswire&amp;utm_medium=pressrelease&amp;utm_campaign=spr\">Cancer Anorexia Cachexia Syndrome (CACS) Market<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">DelveInsight&#8217;s <strong>&#8220;Cancer Anorexia-Cachexia Syndrome (CACS) &#8211; Market Insights, Epidemiology, and Market Forecast-2032&#8221;<\/strong> report delivers an in-depth understanding of the Cancer Anorexia-Cachexia Syndrome (CACS), historical and forecasted epidemiology as well as the Cancer Anorexia-Cachexia Syndrome (CACS) market trends in the 7MM.<\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\"><strong>About DelveInsight<\/strong><\/p>\n<p style=\"text-align: justify;\" dir=\"ltr\">DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com\/_57048.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Sandeep Joshi<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=cancer-cachexia-market-industry-trends-companies-drugs-and-analysis-by-delveinsight\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 9193216187<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> NV<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"http:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"http:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=cancer-cachexia-market-industry-trends-companies-drugs-and-analysis-by-delveinsight\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cancer Cachexia Market The total Cancer Cachexia market size will include the market size of both potential upcoming Cancer Cachexia therapies and current Cancer Cachexia treatment regimens. DelveInsight&rsquo;s Cancer Cachexia market report thoroughly explains Cancer Cachexia, historical and forecasted epidemiology, &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/cancer-cachexia-market-industry-trends-companies-drugs-and-analysis-by-delveinsight_583343.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,406,420,403,404],"tags":[],"class_list":["post-583343","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Science","category-UK","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/583343","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=583343"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/583343\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=583343"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=583343"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=583343"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}